Chlamydial female pelvic inflammatory disease
ICD-10 A56.11 is a billable code used to indicate a diagnosis of chlamydial female pelvic inflammatory disease.
Chlamydial female pelvic inflammatory disease (PID) is an infection of the female reproductive organs caused by the bacterium Chlamydia trachomatis. This condition often arises from untreated chlamydial infections, which are among the most common sexually transmitted infections (STIs) worldwide. PID can lead to serious complications, including chronic pelvic pain, infertility, and ectopic pregnancy. Symptoms may include lower abdominal pain, fever, unusual vaginal discharge, and pain during intercourse. Diagnosis typically involves a combination of clinical evaluation, laboratory testing for chlamydia, and imaging studies to assess the extent of the infection. Treatment usually consists of antibiotics, and it is crucial to treat sexual partners to prevent reinfection. Regular screening for STIs is recommended for sexually active women under 25 and those with risk factors, as early detection and treatment can significantly reduce the risk of complications associated with PID.
Detailed patient history, physical examination findings, laboratory results, and treatment plans.
Diagnosis and management of PID, routine STI screenings, and treatment of chlamydial infections.
Ensure documentation reflects the severity of the infection and any complications.
Comprehensive documentation of diagnostic tests, treatment regimens, and follow-up care.
Management of complex cases of PID with multiple STIs or recurrent infections.
Focus on the need for thorough contact tracing and partner management.
Used when testing for chlamydia in patients with suspected PID.
Document the reason for testing and results.
Gynecologists should ensure comprehensive STI screening.
Common symptoms include lower abdominal pain, fever, unusual vaginal discharge, and pain during intercourse. Some women may be asymptomatic.
Diagnosis is typically made through a combination of clinical evaluation, laboratory testing for chlamydia, and imaging studies such as ultrasound.
Treatment usually involves antibiotics, and it is essential to treat sexual partners to prevent reinfection.
Contact tracing helps to identify and treat sexual partners, reducing the risk of reinfection and further transmission of the infection.
